$EDIT Editas Medicine, Inc. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Editas Medicine, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Editas Medicine, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Editas Medicine, Inc. for free.
IRS Number: 464097528
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: EDIT
Company Address: 11 HURLEY ST. CAMBRIDGE 02141
Phone number: 617-401-9000
Market Capitalization: $636.78M
Prev close: $18.56
Average Daily Volume: 358,194
Days Low: $17.70
Year Low: $12.43
Year High: $43.99
Editas Medicine, Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 16 2021 | EDIT | Editas Medicine, I ... | Shearman Mark S | EVP, Chief Scientif ... | Option Exercise | A | 38.53 | 52,718 | 2,031,225 | 52,718 | |
| Jun 16 2021 | EDIT | Editas Medicine, I ... | Shearman Mark S | EVP, Chief Scientif ... | Grant | A | 0.00 | 32,701 | 0 | 32,701 | 0 to 32.7 K |
| Mar 05 2021 | EDIT | Editas Medicine, I ... | Hopfield Jessica | Director | Buy | P | 45.51 | 5,800 | 263,970 | 22,700 | 16.9 K to 22.7 K (+34.32 %) |
| Mar 04 2021 | EDIT | Editas Medicine, I ... | MULLEN JAMES C | CEO | Option Exercise | A | 45.69 | 196,637 | 8,984,345 | 196,637 | |
| Mar 04 2021 | EDIT | Editas Medicine, I ... | MULLEN JAMES C | CEO | Buy | P | 46.27 | 25,000 | 1,156,800 | 35,000 | 10 K to 35 K (+250.00 %) |
| Feb 10 2021 | EDIT | Editas Medicine, I ... | Collins Cynthia | CEO | Sell | S | 66.65 | 1,262 | 84,112 | 43,760 | 45 K to 43.8 K (-2.80 %) |
| Jan 13 2021 | EDIT | Editas Medicine, I ... | ROBERTSON MICHELLE | Chief Financial Off ... | Sell | S | 78.27 | 1,568 | 122,727 | 18,432 | 20 K to 18.4 K (-7.84 %) |
| Dec 18 2020 | EDIT | Editas Medicine, I ... | Chatterjee Meeta | Director | Option Exercise | A | 62.71 | 23,076 | 1,447,096 | 23,076 | |
| Dec 17 2020 | EDIT | Editas Medicine, I ... | Albright Charles | EVP/Chief Scientifi ... | Option Exercise | M | 16.51 | 10,000 | 165,100 | 145,000 | |
| Dec 17 2020 | EDIT | Editas Medicine, I ... | Albright Charles | EVP/Chief Scientifi ... | Sell | S | 64.39 | 200 | 12,878 | 24,907 | 25.1 K to 24.9 K (-0.80 %) |
| Dec 17 2020 | EDIT | Editas Medicine, I ... | Albright Charles | EVP/Chief Scientifi ... | Sell | S | 63.84 | 4,024 | 256,892 | 25,107 | 29.1 K to 25.1 K (-13.81 %) |
| Dec 17 2020 | EDIT | Editas Medicine, I ... | Albright Charles | EVP/Chief Scientifi ... | Sell | S | 62.74 | 5,776 | 362,386 | 29,131 | 34.9 K to 29.1 K (-16.55 %) |
| Dec 17 2020 | EDIT | Editas Medicine, I ... | Albright Charles | EVP/Chief Scientifi ... | Buy | M | 16.51 | 10,000 | 165,100 | 34,907 | 24.9 K to 34.9 K (+40.15 %) |
| Dec 11 2020 | EDIT | Editas Medicine, I ... | Albright Charles | EVP/Chief Scientifi ... | Option Exercise | M | 16.51 | 10,000 | 165,100 | 155,000 | |
| Dec 11 2020 | EDIT | Editas Medicine, I ... | Albright Charles | EVP/Chief Scientifi ... | Sell | S | 45.00 | 10,000 | 450,000 | 24,907 | 34.9 K to 24.9 K (-28.65 %) |